TandemAI and Perpetual Medicines Announce Strategic Merger to Expand Physics and AI-Based Drug Discovery Capabilities
SHANGHAI & NEW YORK & BOSTON--(BUSINESS WIRE)--Jul 10, 2025-- TandemAI, a company transforming drug discovery with state-of-the-art AI and physics-based technologies integrated with full wet lab capabilities, and Perpetual Medicines, which is …